You are here: Home » International » News » Economy
Business Standard

US trade representative yet to make recommendation on Covid-19 TRIPS waiver

US Trade Representative Katherine Tai has not yet made a recommendation to President Joe Biden on India and South Africa's proposal before the WTO to temporary waive some of the TRIPS during the Covid

US trade policy | Joe Biden

Press Trust of India  |  Washington 

Katherine Tai
Katherine Tai, US trade representative

US Trade Representative Katherine Tai has not yet made a recommendation to President on India and South Africa's proposal before the WTO to temporary waive some of the Trade-Related Aspects of Intellectual Property Rights (TRIPS) during the COVID-19 emergency, the White House has said.

The World Trade Organisation (WTO) during its general council meeting in Geneva on May 5 and 6 is scheduled to take up the proposal.

After regular agenda items, TRIPS waiver proposal is on top of the list of WTO's general council.

Several Democratic lawmakers have launched #FreeTheVaccine campaign in support of India and South Africa.

"We will have something to say about this once the WTO session gets underway. Obviously, Ambassador Tai would be making a recommendation to the president. That's not something that has happened at this point, White House Press Secretary Jen Psaki told reporters at her daily news conference.

"While we're talking about the United States position, it's a WTO process, and what ultimately happens here will not be up to the United States alone, Psaki said.

In a communique to the WTO on October 2, 2020, India and South Africa had called for TRIPS waiver of certain intellectual property provisions of COVID-19 vaccines so that people in developing countries get access to the life-saving vaccines and therapeutics as soon as possible.

"Given this present context of global emergency, it is important for WTO members to work together to ensure that intellectual property rights such as patents, industrial designs, copyright and protection of undisclosed information do not create barriers to the timely access to affordable medical products including vaccines and medicines or to scaling-up of research, development, manufacturing and supply of medical products essential to combat COVID-19, India and South Africa had said in a joint communication.

India and South Africa are now supported by scores of countries, hundreds of non-profit organisations, advocacy groups and rights bodies.

The previous Trump administration had opposed this proposal. The Republican party, which is now in the opposition, has expressed its opposition to the proposal.

A group of GOP senators and Congressmen have written to Biden and Tai respectively.

US industry, pharma companies and eminent philanthropists like Bill Gates too are opposed to COVID-19 IP waiver.

However, more than 100 Democratic lawmakers have come out in support of the move by India and South Africa.

They have written letters to Biden on this issue and have been very vocal in the public domain as well.

The White House and the US trade representative for the past one month are having extensive consultations with various stakeholders over the issue.

Diplomats from India and South Africa have been coordinating to reach out to US policy makers and lawmakers in this regard.

On Monday, India's Ambassador to the US Taranjit Singh Sandhu had a virtual meeting with Kenyan Ambassador to the US, Lazarus O Amayo.

"Discussed issues relating to cooperation in affordable COVID-19 vaccines and therapeutics to ensure global public health and strengthen the fight against the pandemic," Sandhu had tweeted.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, May 05 2021. 06:33 IST